Published in AIDS Weekly, December 12th, 2005
Cellegy had a net loss of $3,143,000 or $0.14 per basic and diluted common share during the same period in 2004. Cellegy's cumulative net loss for the 9-month period in 2005 was $3,044,000 or $0.11 per basic and diluted common share compared to a net loss of $8,909,000 or $0.43 per common share during the same period last year.
Revenues for the quarters ended September 30, 2005 and 2004 were $1,952,000 and $483,000, respectively. For the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.